As we are sure many of you are aware, there is widespread news coverage regarding Monkey Pox, with the UK Health Security Agency (UKSA) today reporting a further eleven cases.
We understand this may cause concern amongst many of you, particularly as this is happening in the wake of Covid-19. However, we would like to highlight that current UKHSA guidance is that the virus does not usually spread easily, and the risk to people is low. Investigations are ongoing, and contact tracing is underway to look at possible modes of transmission and prevent further spread.
What is Monkeypox?
Monkeypox is a zoonotic (can be spread from animals to humans) viral infection that is endemic in parts of the west and central Africa.
How is monkeypox spread?
The virus is spread through close physical contact with an infected individual or through contact with blood, bodily fluids, or cutaneous or mucosal lesions of infected individuals or animals. It can also be spread through contact with clothing or linens used by an infected person.
It is worth noting that monkeypox is NOT predominantly a respiratory virus so will not spread in the same way as COVID-19 and is unlikely to affect people with pre-existing respiratory disease in the same way.
Symptoms
Initial symptoms of monkeypox include:
- fever
- headache
- muscle aches
- backache
- swollen lymph nodes
- shivering
- exhaustion
A rash usually appears 1 – 5 days after the first symptoms, often beginning on the face and then spreading to other parts of the body, particularly the hands and feet.
The rash (which can look like chickenpox) starts as raised spots, which turn into small blisters filled with fluid. These blisters eventually form scabs which later fall off. Symptoms are usually mild and self-limiting and typically clear up in 2 to 4 weeks.
Anyone with concerns that they could be infected with monkeypox is advised to contact NHS 111 or a sexual health clinic.
More information can be found via the link below.
Share this post
Latest News posts
The Benefits of Peer Support
March 25, 2023
2023 Bronchiectasis Patient Conference
March 23, 2023
Fungal vaccine developments
March 22, 2023
Asthma UK’s End the Lung Health Lottery
March 21, 2023
Secondary Adrenal Insufficiency
March 17, 2023
IgG and IgE explained
March 14, 2023
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video